Posts

Luísa Figueiredo was elected as an EMBO member

The European Molecular Biology Organization (EMBO) has announced today that it w...

Fat-free mass-based dosing: A superior antibiotic regim...

Gentamicin is a common antibiotic used to treat critically ill neonates. It is w...

Sea of plastic: Mediterranean is the area of the world ...

New study reveals the areas most at risk of plastic exposure by the already enda...

Korea University Medicine study highlights a new biomar...

In appearance, the human brain’s outermost layer, called the cortex, is a maze o...

World’s most threatened seabirds visit remote plastic p...

  Credit: Beth Clark UNDER STRICT EMBARGO UNTIL 16:00 LONDON TIME (BST) / 11:00 ...

Knowledge powerhouses urged to join pioneering Africa-l...

Global institutions are today being called on to back a bold, transformative pla...

Vineyard fungicides pose a threat to survival of wild b...

New research reveals that wild birds living in vineyards can be highly susceptib...

Chime Biologics, Leads and Beigene enter antibody devel...

Chime Biologics, Leads Biolabs and BeiGene have entered a strategic partnership ...

Zealand Pharma submits NDA for hyperinsulinism drug das...

The NDA includes pivotal data from Phase III trials and a long-term extension, w...

The VPAS fallout continues – Celltrion pulls high-profi...

In late June 2023, Celltrion (South Korea) withdrew its key anti-cancer biosimil...

Camena bags $10m in funding from Mercia

The bioscience company has received $10m Series A financing from asset manager M...

Baudax Bio acquires biotechnology firm TeraImmune

Baudax Bio has acquired all outstanding equity interests of biotechnology firm T...

Generative AI – beyond the hype

2023 started with a buzz around ChatGPT, and more generally around the immense p...

Cyltezo Pen: first interchangeable biosimilar to Humira...

The Humira biosimilar from Boehringer Ingelheim launches amidst a loss of exclus...

Eli Lilly’s retatrutide sets new record for weight loss...

Pipeline developments within the obesity space have recently garnered interest f...

Chinese NMPA approves Innovent and IASO Bio’s myeloma t...

China has granted approval for Innovent Biologics and IASO Bio Fucaso for treati...